title: Analysis of the DMBT1 gene in carcinomas of the respiratory tract.
abstract: Loss of chromosome 10q is a critical step during the progression and metastasis formation of lung cancer. We recently defined 3 distinct regions of allelic imbalances and considered the DMBT1 gene at 10q25-q26 an interesting candidate for the most telomeric region. Therefore, we investigated DMBT1 in 25 cancer cell lines and 39 primary tumors of the respiratory tract. The analysis by RT-PCR and Northern blot hybridization revealed that the gene is expressed in all tumors and cell lines and diminished in the SCLC line H187, indicating that RT-PCR is critical when used as the single method for the evaluation of gene expression. No mutations were found by SSCP analysis of the cDNA and the partially known genomic sequence. Similarly, Southern blot hybridization was unable to detect homozygous deletions. Allelotyping of the markers D10S587, D10S1708 and D10S1723 located near or within the DMBT1 gene did not reach the peak incidence of the 3 minimally deleted regions that we recently defined. In summary, our data do not confirm previous findings reporting frequent loss of DMBT1 expression in lung cancer. However, they strengthen the notion that the responsible gene on chromosome 10q25-q26 mediating tumor progression and metastasis formation in respiratory tract cancer remains enigmatic.
authors.affiliation: Institute of Pathology, University Hospital Charité, Berlin, Germany.
authors.forename: S
authors.initials: S
authors.lastname: Petersen
authors.forename: J
authors.initials: J
authors.lastname: Rudolf
authors.forename: U
authors.initials: U
authors.lastname: Bockmühl
authors.forename: N
authors.initials: N
authors.lastname: Deutschmann
authors.forename: M
authors.initials: M
authors.lastname: Dietel
authors.forename: I
authors.initials: I
authors.lastname: Petersen
mesh_terms: D000373:Agglutinins; D000483:Alleles; D001483:Base Sequence; D015152:Blotting, Northern; D001984:Bronchial Neoplasms / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D002135:Calcium-Binding Proteins; D002277:Carcinoma / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D002289:Carcinoma, Non-Small-Cell Lung / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D018288:Carcinoma, Small Cell / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D002294:Carcinoma, Squamous Cell / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D004252:DNA Mutational Analysis; D004268:DNA-Binding Proteins; D018450:Disease Progression; D017353:Gene Deletion; D015870:Gene Expression; D006258:Head and Neck Neoplasms / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D006801:Humans; D008175:Lung Neoplasms / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D009693:Nucleic Acid Hybridization; D018807:Polymorphism, Single-Stranded Conformational; D011956:Receptors, Cell Surface / Q000096:biosynthesis / Q000235:genetics*; D012142:Respiratory Tract Neoplasms / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014407:Tumor Cells, Cultured; D025521:Tumor Suppressor Proteins
chemical_list: D000373:Agglutinins; D002135:Calcium-Binding Proteins; C108174:DMBT1 protein, human; D004268:DNA-Binding Proteins; D011956:Receptors, Cell Surface; D025521:Tumor Suppressor Proteins